去泛素化酶在调控DNA损伤应答和基因组稳定性中的作用机制及其与肿瘤的关系

DNA损伤会造成基因组的不稳定，导致肿瘤等恶性疾病的发生。泛素化等翻译后修饰在DNA损伤应答（DDR）调节中发挥重要作用，DDR中关键蛋白的泛素化和去泛素化修饰的精细调控，对于在损伤初期细胞有效应答和在修复完成后及时地终止修复至关重要，去泛素化酶也因而成为肿瘤治疗的潜在靶标。针对DDR中去泛素化酶对组蛋白等的调控作用机制及其对放化疗敏感性的影响开展深入研究具有重要生物学意义。我们的前期工作发现了一些DDR关键蛋白H2A等的去泛素化酶。在此基础上，本课题将深入研究这些去泛素化酶是如何通过调控组蛋白的修饰以及染色质结构影响基因组的稳定性，揭示其在DDR中发挥作用的分子机制；同时，探讨其表达异常或酶活性缺失对肿瘤细胞生存、突变、放化疗敏感性以及成瘤的影响,明确其与肿瘤发生发展和耐药的关系。这些研究有助于揭示肿瘤细胞放化疗耐受的形成机制，为增加放化疗敏感性并显著改善肿瘤病人的预后提供有用信息。

DNA damage induced by numerous internal and environmental hazards triggers genomic instability, and ultimately promotes tumorigenesis. To cope with these damages, cells have developed a DNA damage response (DDR) system to sense and repair DNA lesions. Various protein modifications play important roles during DNA damage response. Among them, the fine-tuning regulations of the ubiquitination and deubiquitination of the key proteins in DDR play critical roles in the early response to the damage and also the termination of repair. Therefore, deubiquitinases are become new therapeutic options in cancer therapy. To identify more deubiquitinases involved in DDR and elucidate their mechanisms and correlation with the tolerance to drug and radiation treatments are of great importance. Our previous study has found some deubiquitin enzymes and factors that can deubiquitinate H2A and PCNA in response to DNA damage. In this study, we will systematiclly investigate the functions and underlying mechanisms of these regulators in DNA damage response, to understand the effects of deubiquitination on the modifications of histone proteins, the chromatin structure, the recruitment of DNA damage repair proteins, and the genomic stability. Moreover, we will also elucidate the effects of depleted-deubiquitinases on tumor cells growth, mutations, sensitivity to chemotherapy and radiotherapy, and tumorigenesis. These studies will help us to further understand the molecular mecahnisms of tumorigenesis and drug resistance, and provide useful information for increasing the radiation and chemotherapy sensitivity and improving the prognosis of tumor patients, and also provide insight for finding novel targets in tumor diagnosis and treatment in the future.